Oxidation of low density lipoprotein in hemodialysis patients: Effect of dialysis and comparison with matched controls

被引:42
作者
Westhuyzen, J [1 ]
Saltissi, D [1 ]
Healy, H [1 ]
机构
[1] ROYAL BRISBANE HOSP,DEPT RENAL MED,HERSTON,QLD 4029,AUSTRALIA
关键词
atherosclerosis; fatty acids; hemodialysis; lipid peroxidation; lipoproteins; low density lipoprotein; lysine;
D O I
10.1016/S0021-9150(96)06040-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
End stage renal failure is associated with lipoprotein abnormalities and a high prevalence of premature atherosclerosis. Oxidative modification of low density lipoprotein (LDL) may be promoted by hemodialysis increasing its atherogenicity. The oxidative status of LDL was therefore examined in female subjects before and after routine hemodialysis (HD; n = 10) and compared with women of similar age without significant renal disease (n = 19). There were no significant differences between the groups in the LDL fatty acid composition, or in the content of reactive amino acid groups (lysine) before or after exposure to Cu2+. The kinetics of LDL oxidation by Cu2+ showed no significant differences between the groups with respect to the lag time, the level of conjugated dienes before and after oxidation, or the maximal rate of oxidation during the propagation phase. No acute effects of HD were demonstrated. The present study provides no evidence that circulating LDL isolated from HD patients is more extensively modified or more susceptible to oxidation in vitro than gender-matched controls without renal failure. (C) 1997 Elsevier Science Ireland Ltd.
引用
收藏
页码:199 / 205
页数:7
相关论文
共 48 条
[1]   OXIDATION OF LOW-DENSITY LIPOPROTEINS - INTRAINDIVIDUAL VARIABILITY AND THE EFFECT OF DIETARY LINOLEATE SUPPLEMENTATION [J].
ABBEY, M ;
BELLING, GB ;
NOAKES, M ;
HIRATA, F ;
NESTEL, PJ .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1993, 57 (03) :391-398
[2]   LIPID ABNORMALITIES IN RENAL-DISEASE [J].
APPEL, G ;
SCHAEFER, E ;
MADIAS, NE ;
MADAIO, MP ;
HARRINGTON, JT ;
LEVEY, AS ;
NARAYAN, G ;
MEYER, K .
KIDNEY INTERNATIONAL, 1991, 39 (01) :169-183
[3]  
ATTMAN PO, 1991, KIDNEY INT S31, V39, P516
[4]  
AVIRAM M, 1995, ISRAEL J MED SCI, V31, P241
[5]  
Avram M M, 1989, Am J Med, V87, p55N
[6]   COMPARATIVE MORTALITY FROM CARDIOVASCULAR-DISEASE IN PATIENTS WITH CHRONIC-RENAL-FAILURE [J].
BROWN, JH ;
HUNT, LP ;
VITES, NP ;
SHORT, CD ;
GOKAL, R ;
MALLICK, NP .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1994, 9 (08) :1136-1142
[7]   INCREASED LIPID-PEROXIDATION IN PATIENTS ON MAINTENANCE HEMODIALYSIS [J].
DASGUPTA, A ;
HUSSAIN, S ;
AHMAD, S .
NEPHRON, 1992, 60 (01) :56-59
[8]   THE ROLE OF LIPID-PEROXIDATION AND ANTIOXIDANTS IN OXIDATIVE MODIFICATION OF LDL [J].
ESTERBAUER, H ;
GEBICKI, J ;
PUHL, H ;
JURGENS, G .
FREE RADICAL BIOLOGY AND MEDICINE, 1992, 13 (04) :341-390
[9]   LIPID-PEROXIDATION AND ITS ROLE IN ATHEROSCLEROSIS [J].
ESTERBAUER, H ;
WAG, G ;
PUHL, H .
BRITISH MEDICAL BULLETIN, 1993, 49 (03) :566-576
[10]   THIOBARBITURIC ACID REACTIVE MATERIAL IN UREMIC BLOOD [J].
FILLIT, H ;
ELION, E ;
SULLIVAN, J ;
SHERMAN, R ;
ZABRISKIE, JB .
NEPHRON, 1981, 29 (1-2) :40-43